Table. 1 The Clinical characteristics of hepatocellular carcinoma patients obtained from TCGA database
From: The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma
Clinical characteristics | Total (377) | % |
|---|---|---|
Age | 61 (16–90) |  |
G stage | ||
 G1 | 55 | 14.82 |
 G2 | 180 | 48.51 |
 G3 | 124 | 33.42 |
 G4 | 12 | 3.25 |
Clinical stage | ||
 Stage I | 175 | 49.58 |
 Stage II | 87 | 24.65 |
 Stage III | 86 | 24.36 |
 Stage IV | 5 | 1.41 |
Sex | ||
 Female | 122 | 32.36 |
 Male | 255 | 67.64 |
T stage | ||
 T1 | 185 | 49.47 |
 T2 | 95 | 25.40 |
 T3 | 81 | 21.66 |
 T4 | 13 | 3.47 |
N stage | ||
 N0 | 257 | 98.46 |
 N1 | 4 | 1.54 |
M stage | ||
 M0 | 272 | 98.55 |
 M1 | 4 | 1.45 |